HSPH1 and colorectal cancer: In a recent study, Gozzi [145] designed a novel NBD-binding small molecule inhibitor which compromises Hsp110 chaperone function, thereby inhibiting STAT3 phosphorylation and colorectal cancer cell proliferation.